ENS 43434: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (Created page by program invented by Mark Hawes) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
| facility = Oregon Health Science University | | facility = Oregon Health Science University | ||
| Organization = Or Dept Of Health Rad Protection | | Organization = Or Dept Of Health Rad Protection | ||
| license number = | | license number = ORE-90013 | ||
| region = 4 | | region = 4 | ||
| state = Oregon | | state = Oregon | ||
| Line 16: | Line 16: | ||
| event date = 06/18/2007 16:00 PDT | | event date = 06/18/2007 16:00 PDT | ||
| last update date = 06/20/2007 | | last update date = 06/20/2007 | ||
| title = Oregon Agreement State Report - Potential Underdose Treatment | | title = Oregon Agreement State Report - Potential Underdose Treatment to Liver | ||
| event text = Written order was requested for a therapy dose of 2.45 GBq (66.2 milliCuries) of Y-90 TheraSphere for treatment to the patient's liver. 1.74 GBq (47 milliCuries) was received from MDS Nordion and used for treatment. Calculation error may have contributed to under treatment with approximately 80 Gray delivered to the liver with an intended dose of 100-110 Gray. Concern to not exceed lung dose of 15 Gray achieved with treatment dose at low end of optimal range. Physician notified and will consult with patient to decide whether to conduct additional treatment. | | event text = Written order was requested for a therapy dose of 2.45 GBq (66.2 milliCuries) of Y-90 TheraSphere for treatment to the patient's liver. 1.74 GBq (47 milliCuries) was received from MDS Nordion and used for treatment. Calculation error may have contributed to under treatment with approximately 80 Gray delivered to the liver with an intended dose of 100-110 Gray. Concern to not exceed lung dose of 15 Gray achieved with treatment dose at low end of optimal range. Physician notified and will consult with patient to decide whether to conduct additional treatment. | ||
A "Medical Event" may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient. | A "Medical Event" may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient. | ||
Latest revision as of 18:32, 24 November 2018
| Where | |
|---|---|
| Oregon Health Science University Portland, Oregon (NRC Region 4) | |
| License number: | ORE-90013 |
| Organization: | Or Dept Of Health Rad Protection |
| Reporting | |
| Agreement State | |
| Time - Person (Reporting Time:+43.9 h1.829 days <br />0.261 weeks <br />0.0601 months <br />) | |
| Opened: | Terry Lindsey 18:54 Jun 20, 2007 |
| NRC Officer: | Jeff Rotton |
| Last Updated: | Jun 20, 2007 |
| 43434 - NRC Website | |